Chair Jeanne Shaheene
Senator Shaheen is committed to serving the citizens of New Hampshire and is known for her common-sense leadership, hard work and dedication to improving the lives of the middle class. She has served in the Senate since 2009 and is a member of the Senate Committees on Armed Services, Foreign Relations, Appropriations, Small Business and Entrepreneurship and the Select Committee on Ethics.
As a former small business owner, Senator Shaheen knows how tough it can be for entrepreneurs, who often operate on razor thin profit margins. On the Small Business Committee, she’s expanded small businesses’ access to credit and markets. Her annual Experience New Hampshire event in Washington, D.C., gives New Hampshire businesses a forum to showcase their products and services to policymakers and government officials. Shaheen continues to lead efforts in the Senate to protect New Hampshire businesses from having to unfairly collect internet sales taxes for other states.
The opioid epidemic is the worst public health crisis in New Hampshire’s history, and Senator Shaheen has made fighting this crisis her number one priority in Congress. Through her leadership on the Appropriations committee, Senator Shaheen worked to deliver a seven fold increase in resources to help Granite Staters suffering from substance use disorders receive desperately needed treatment. She works across the aisle to provide tools that treatment providers, law enforcement and first responders need to deliver lifesaving services.
Shaheen helped pass the Affordable Care Act, and has defended the law from partisan attacks, ensuring that tens of thousands of Granite Staters can keep their health care. The law drastically expanded the availability of drug treatment in New Hampshire through Medicaid Expansion, a vital tool to address the opioid crisis, and provided protections to people with pre-existing conditions. She continues to lead efforts in the Senate to advance common-sense health care legislation that would expand access to care and lower the costs of both treatment and prescription drugs.